☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Zion Pharma
Zion Pharma Signs an Agreement with Roche to Develop and Commercialize ZN-A-1041 for HER2-Positive Breast Cancer
May 10, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.